Ebola Virus Shed Glycoprotein Triggers Differentiation, Infection, and Death of Monocytes Through Toll-Like Receptor 4 Activation

Journal of Infectious Diseases

Volumn 218, Issue , 2018, Pages S327-S334

  Iampietro, Mathieu ^a,b   Santos, Rodrigo I ^a,b   Lubaki, Ndongala Michel ^a,b   Bukreyev, Alexander ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

differentiation; Ebola virus; infection; shed GP; Toll like receptor.

Indexed keywords

TOLL LIKE RECEPTOR 4; VIRUS GLYCOPROTEIN; EBOLA VACCINE; GLYCOPROTEIN; TLR4 PROTEIN, HUMAN; VIRUS ENVELOPE PROTEIN;

CELL ACTIVATION; CELL DEATH; CELL DIFFERENTIATION; CONFERENCE PAPER; CONTROLLED STUDY; EBOLA HEMORRHAGIC FEVER; HUMAN; HUMAN CELL; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SUPERNATANT; VIRUS INFECTIVITY; VIRUS SHEDDING; EBOLAVIRUS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; THP-1 CELL LINE; VIROLOGY;

CELL DEATH; CELL DIFFERENTIATION; EBOLA VACCINES; EBOLAVIRUS; GLYCOPROTEINS; HEMORRHAGIC FEVER, EBOLA; HOST-PATHOGEN INTERACTIONS; HUMANS; MONOCYTES; THP-1 CELLS; TOLL-LIKE RECEPTOR 4; VIRAL ENVELOPE PROTEINS;

EID: 85057158249     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiy406     Document Type: Conference Paper

References (30)

1. Centers for Disease Control and Prevention. 2014 Ebola Outbreak in West Africa-Case Counts 2016. Available at: http://www. cdc. gov/vhf/ebola/outbreaks/ 2014-west-africa/case-counts. html. Accessed 22 January 2018.
2. Prescott JB, Marzi A, Safronetz D, Robertson SJ, Feldmann H, Best SM. Immunobiology of Ebola and Lassa virus infections. Nat Rev Immunol. 2017; 17:195-207.
3. Baize S, Leroy EM, Georges AJ, et al. Inflammatory responses in Ebola virus-infected patients. Clin Exp Immunol 2002; 128:163-8.
4. Geisbert TW, Hensley LE, Larsen T, Young HA, Reed DS, Geisbert JB, et al. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am J Pathol. 2003; 163:2347-70.
5. Lubaki NM, Ilinykh P, Pietzsch C, et al. The lack of maturation of Ebola virus-infected dendritic cells results from the cooperative effect of at least two viral domains. J Virol 2013; 87:7471-85.
6. Mahanty S, Hutchinson K, Agarwal S, McRae M, Rollin PE, Pulendran B. Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses. J Immunol 2003; 170:2797-801.
7. Bosio CM, Aman MJ, Grogan C, et al. Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation. J Infect Dis 2003; 188:1630-8.
8. Sanchez A, Kiley MP, Holloway BP, Auperin DD. Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus. Virus Res 1993; 29:215-40.
9. Dolnik O, Volchkova V, Garten W, et al. Ectodomain shedding of the glycoprotein GP of Ebola virus. EMBO J 2004; 23:2175-84.
10. Rubins KH, Hensley LE, Wahl-Jensen V, et al. The temporal program of peripheral blood gene expression in the response of nonhuman primates to Ebola hemorrhagic fever. Genome Biol 2007; 8:R174.
11. Okumura A, Pitha PM, Yoshimura A, Harty RN. Interaction between Ebola virus glycoprotein and host Toll-like receptor 4 leads to induction of proinflammatory cytokines and SOCS1. J Virol 2010; 84:27-33.
12. Escudero-Perez B, Volchkova VA, Dolnik O, Lawrence P, Volchkov VE. Shed GP of Ebola virus triggers immune activation and increased vascular permeability. PLoS Pathog 2014; 10:e1004509.
13. Towner JS, Paragas J, Dover JE, et al. Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening. Virology 2005; 332:20-7.
14. Garbutt M, Liebscher R, Wahl-Jensen V, et al. Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses. J Virol 2004; 78:5458-65.
15. Bukreyev A, Marzi A, Feldmann F, et al. Chimeric human parainfluenza virus bearing the Ebola virus glycoprotein as the sole surface protein is immunogenic and highly protective against Ebola virus challenge. Virology 2009; 383:348-61.
16. Iampietro M, Younan P, Nishida A, et al. Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lack of infection. PLoS Pathog 2017; 13:e1006397.
17. Martinez O, Johnson JC, Honko A, et al. Ebola virus exploits a monocyte differentiation program to promote its entry. J Virol 2013; 87:3801-14.
18. Mukherjee R, Kanti Barman P, Kumar Thatoi P, Tripathy R, Kumar Das B, Ravindran B. Non-classical monocytes display inflammatory features: validation in sepsis and systemic lupus erythematous. Sci Rep 2015; 5:13886.
19. Betjes MG, Haks MC, Tuk CW, Beelen RH. Monoclonal antibody EBM11 (anti-CD68) discriminates between dendritic cells and macrophages after shortterm culture. Immunobiology 1991; 183:79-87.
20. Chistiakov DA, Killingsworth MC, Myasoedova VA, Orekhov AN, Bobryshev YV. CD68/macrosialin: not just a histochemical marker. Lab Invest 2017; 97:4-13.
21. Dahlmann F, Biedenkopf N, Babler A, Jahnen-Dechent W, Karsten CB, Gnirss K, et al. Analysis of Ebola virus entry into macrophages. J Infect Dis 2015; 212(Suppl 2):S247-57.
22. Edwards MR, Liu G, Mire CE, et al. Differential regulation of interferon responses by Ebola and Marburg virus VP35 Proteinsp Cell Rep 2016; 14:1632-40.
23. Aldo PB, Craveiro V, Guller S, Mor G. Effect of culture conditions on the phenotype of THP-1 monocyte cell line. Am J Reprod Immunol 2013; 70:80-6.
24. Bosshart H, Heinzelmann M. Lipopolysaccharide-mediated cell activation without rapid mobilization of cytosolic free calcium. Mol Immunol 2004; 41:1023-8.
25. Yuan A, Hsiao YJ, Chen HY, et al. Opposite effects of M1 and M2 macrophage subtypes on lung cancer progression. Sci Rep 2015; 5:14273.
26. Genin M, Clement F, Fattaccioli A, Raes M, Michiels C. M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide. BMC Cancer 2015; 15:577.
27. Takashiba S, Van Dyke TE, Amar S, Murayama Y, Soskolne AW, Shapira L. Differentiation of monocytes to macrophages primes cells for lipopolysaccharide stimulation via accumulation of cytoplasmic nuclear factor kappaB. Infect Immun 1999; 67:5573-8.
28. Marzi A, Feldmann H. Ebola virus vaccines: An overview of current approaches. Expert Rev Vaccines 2014; 13:521-31.
29. Huttner A, Dayer JA, Yerly S, et al. The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: A randomised double-blind, placebo-controlled phase 1/2 trial. Lancet Infect Dis 2015; 15:1156-66.
30. Younan P, Ramanathan P, Graber J, Gusovsky F, Bukreyev A. The Toll-like receptor 4 antagonist eritoran protects mice from lethal filovirus challenge. MBio 2017; 8:e00226-17.